Hexachlorophene as a topically applied chemical for prophylaxis against Schistosoma mansoni infections in mice.
Explore the source record for details and available documents.
Administration, Topical↗
Biomedical subjects
D H Jones
Publications and source records attributed to D H Jones.
Under the midnight sun.
Explore the source record for details and available documents.
Adaptation, Psychological↗
Behavioral risk factors in an Amish community.
A representative sample of 400 Amish adults residing in Holmes County, Ohio, was interviewed about certain health risk characteristics and behaviors, using the Behavioral Risk Factor Survey (BRFS). For purposes of comparison, a representative sample of 773 non-Amish adults responded to the same survey by telephone interviews. In general, the Amish report lower rates of alcohol and tobacco consumption than their non-Amish counterparts. The Amish are less likely to salt their food and are more likely to take vitamin supplements, but do not differ from non-Amish in the consumption of "health foods." Amish men and women are less likely to be trying to lose weight than their non-Amish counterparts. Further, the Amish are less likely to engage in leisure-time physical activity or in exercise associated with attempts to lose weight or deal with hypertension. Amish women are less likely to use seat belts than non-Amish women, whereas men in both groups appear rather similar. Although some differences could be influenced by response biases, many are supported by less systematic observations of Old Order Amish societies. The patterns of health behavior reflect characteristics of Amish culture and may be responsible for certain favorable mortality rates among the Amish population.
Adult↗
Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).
Fifty four patients with squamous cell lung cancer, treated with Cyclophosphamide (750 mg/m2), Adriamycin (50 mg/m2), Vincristine (1.5 mg/m2) and Bleomycin (30 mg) (CAVB) in a 2 day scheduled regime, showed an overall median survival time (MST) of 32 weeks (28 weeks for non-responders and 46.5 weeks for responders--a non-significant difference). The response rate was 24%, the median duration of response being 23 weeks. Bone marrow toxicity was not a major problem. A further 21 patients received the same drugs but in a single bolus (unscheduled regime). Comparison of their results with the 25 patients randomised to the scheduled regime showed no significant difference in MST or toxicity. The addition of Cis-platinum (50 mg/m2) to the unscheduled CAVB regime (CAVBP) in a further 22 patients did not result in an improvement either in survival or response, but added to the toxicity.
Adult↗